Top

Oral Radiology

Published in:

01-09-2017 | Original Article

Effects of dose rate on early and late complications in low dose rate brachytherapy for mobile tongue carcinoma using ¹⁹²Ir sources

Authors: Atsushi Kaida, Hiroshi Watanabe, Kazuma Toda, Keiko Yuasa-Nakagawa, Ryoichi Yoshimura, Masahiko Miura

Published in: Oral Radiology | Issue 3/2017

Abstract

Objectives

Low dose rate brachytherapy using ¹⁹²Ir sources (LDR-BRT) is the definitive radiotherapy for early stage mobile tongue carcinoma. The effects of dose rate on early and late complications require re-evaluation, because the prescribed dose is almost fixed and a spacer has recently been used in all cases. Given this situation, we investigated any adverse effects of dose rate in LDR-BRT.

Methods

For this retrospective study, 116 patients with early tongue cancer treated with LDR-BRT alone at Tokyo Medical and Dental University Medical Hospital between 2008 and 2013 were enrolled. The patients were classified into two groups according to dose rate or biological effective dose. All patients had a spacer in place throughout the treatment period.

Results

The rates of overall survival, local control, and neck node metastasis did not differ significantly between the two groups. Notably, there were no significant differences in the severity or incidence of early or late complications between the two groups.

Conclusions

In the present study, we demonstrated that a dose rate of up to 0.91 Gy/h did not significantly influence the incidence of early or late complications when other factors were well controlled in the presence of a spacer.

Shibuya H, Hoshina M, Takeda M, Matsumoto S, Suzuki S, Okada N. Brachytherapy for stage I & II oral tongue cancer: an analysis of past cases focusing on control and complications. Int J Radiat Oncol Biol Phys. 1993;26:51–8.CrossRefPubMed

Mazeron JJ, Crook JM, Marinello G, Walop W, Pierquin B. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation. Int J Radiat Oncol Biol Phys. 1990;19:281–5.CrossRefPubMed

Bourgier C, Coche-Déquéant B, Fournier C, Castelain B, Prévost B, Lefebvre JL, et al. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma. Int J Radiat Oncol Biol Phys. 2005;63:434–40.CrossRefPubMed

Wadsley JC, Patel M, Tomlins CD, Gildersleve JQ. Iridium-192 implantation for T1 and T2a carcinoma of the tongue and floor of mouth: retrospective study of the results of treatment at the Royal Berkshire Hospital. Br J Radiol. 2003;76:414–7.CrossRefPubMed

Bachaud JM, Delannes M, Allouache N, Benchalal M, Alzieu C, David JM, et al. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth. Radiother Oncol. 1994;31:199–206.CrossRefPubMed

Oota S, Shibuya H, Yoshimura R, Watanabe H, Miura M. Brachytherapy of stage II mobile tongue carcinoma. Prediction of local control and QOL. Radiat Oncol. 2006;1:21.CrossRefPubMedPubMedCentral

Yoshimura R, Shibuya H, Miura M, Watanabe H, Ayukawa F, Hayashi K, et al. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2009;73:772–8.CrossRefPubMed

Curi MM, Oliveira dos Santos M, Feher O, Faria JC, Rodrigues ML, Kowalski LP. Management of extensive osteoradionecrosis of the mandible with radical resection and immediate microvascular reconstruction. J Oral Maxillofac Surg. 2007;65:434–8.CrossRefPubMed

Lozza L, Cerrotta A, Gardani G, De Marie M, Di Russo A, Kenda R, et al. Analysis of risk factors for mandibular bone radionecrosis after exclusive low dose-rate brachytherapy for oral cancer. Radiother Oncol. 1997;44:143–7.CrossRefPubMed

10.

Mazeron JJ, Simon JM, Le Péchoux C, Crook JM, Grimard L, Piedbois P, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol. 1991;21:39–47.CrossRefPubMed

11.

Hall EJ, Giaccia J. Fractionated radiation and the dose-rate effect. In: Hall EJ, Giaccia J, editors. Radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 67–85.

12.

Hall EJ, Giaccia J. Cell survival curves. In: Hall EJ, Giaccia J, editors. Radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 35–53.

13.

Miura M, Takeda M, Sasaki T, Inoue T, Nakayama T, Fukuda H, et al. Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer. Int J Radiat Oncol Biol Phys. 1998;41:763–70.CrossRefPubMed

14.

Fujita M, Tamamoto M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, et al. Experimental and clinical studies on dose reduction effects of spacers in interstitial brachytherapy for carcinoma of the mobile tongue. Oral Surg Oral Med Oral Pathol. 1993;76:797–803.CrossRefPubMed

15.

Obinata K, Ohmori K, Tuchiya K, Nishioka T, Shirato H, Nakamura M. Clinical study of a spacer to help prevent osteoradionecrosis resulting from brachytherapy for tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:246–50.CrossRefPubMed

16.

Marinello G, Wilson JF, Pierquin B, Barret C, Mazeron JJ. The guide gutter or loop techniques of interstitial implantation and the Paris system of dosimetry. Radiother Oncol. 1985;4:265–73.CrossRefPubMed

17.

Dutreix J. Expression of the dose rate effect in clinical curietherapy. Radiother Oncol. 1989;15:25–37.CrossRefPubMed

18.

National Cancer Institute. National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. 2010. https://evs.nci.nih.gov/ftp1/CTCAE/About.html.

19.

Fujita M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, Kiriu H, et al. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys. 1999;44:767–75.CrossRefPubMed

20.

Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys. 1995;33:563–8.CrossRefPubMed

Title: Effects of dose rate on early and late complications in low dose rate brachytherapy for mobile tongue carcinoma using 192Ir sources
Authors: Atsushi Kaida
Hiroshi Watanabe
Kazuma Toda
Keiko Yuasa-Nakagawa
Ryoichi Yoshimura
Masahiko Miura
Publication date: 01-09-2017
Publisher: Springer Singapore
Published in: Oral Radiology / Issue 3/2017
Print ISSN: 0911-6028
Electronic ISSN: 1613-9674
DOI: https://doi.org/10.1007/s11282-016-0263-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Effects of dose rate on early and late complications in low dose rate brachytherapy for mobile tongue carcinoma using ¹⁹²Ir sources

Abstract

Objectives

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2017

Diagnostic value of computed tomography, magnetic resonance imaging, and scintigraphy in diagnosing actinomycosis of the mandible

Cone-beam computed tomography evaluation of palatogingival grooves: a retrospective study with literature review

Basic and important points regarding the diagnosis of oral cancers using fluorine-18-labeled fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography: a review

Upper airway imaging in sleep-disordered breathing: role of cone-beam computed tomography

Clinical significance of intraoral strain elastography for diagnosing early stage tongue carcinoma: a preliminary study

Cone-beam computed tomography investigation of crucial mandibular canal variations in Thais